Wholesale price Simvastatin 40mg Powder supplier

CAS: 79902-63-9

MF: C25H38O5

MW: 418.57

EINECS: 616-751-8

Specification​: 99% min Simvastatin Powder

Sample: Simvastatin Powder Avaliable

Packaging: 1kg/bag, 25kg/drum

Brand: Ausreson

MOQ: 1 kg

Appearance: white to off-white powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Last updated: March 2026

Simvastatin Usage and Synthesis.

Simvastatin is clinically used for primary hypercholesterolaemia, heterozygous familial and non-familial hypercholesterolaemia or mixed hyperlipidaemia where dietary therapy is ineffective, the effect of lowering total cholesterol and LDL cholesterol is remarkable, with obvious efficacy seen within 2 weeks, maximum efficacy occurring in 4-6 weeks, and efficacy can be maintained by continued treatment, and the lipid lowering effect on uncomplicated and well-controlled insulin-dependent and non-insulin-dependent diabetes mellitus hypercholesterolaemia is the same as that in non-diabetes mellitus without compromising the control of blood glucose.

How Simvastatin Reshapes Vitality

• Competitive HMG-CoA Inhibition: Simvastatin mimics the natural substrate, binding to the HMG-CoA reductase enzyme with 1000x higher affinity. This shuts down the Mevalonate Pathway, the primary furnace for endogenous cholesterol production.

• Upregulation of LDL Receptors: By reducing intracellular cholesterol, it triggers the liver to increase LDL receptor density, accelerating the clearance of "bad" cholesterol from the blood.

• Plaque Stabilization & Anti-thrombotic Effects: In 2026, it is prized for its ability to strengthen the fibrous cap of arterial plaques, preventing ruptures that lead to strokes or myocardial infarctions.

• The "Bone-Building" Hack: Emerging 2026 regenerative protocols utilize Simvastatin powder in scaffolding materials to stimulate osteoblast differentiation, offering a novel approach to localized bone repair.

Uses and functions of Simvastatin.

Simvastatin catalyses the conversion of β-methyl-β-hydroxyglutarate coenzyme A (HMG-CoA) to β-methyl-p-α dihydroxyglutarate and is a specific inhibitor of HMG-CoA reductase.

After oral administration, it is hydrolysed to the corresponding β-hydroxy acid, which is one of the effective and safe drugs among the current lipid-lowering drugs, and can reduce serum total cholesterol, low-density lipoprotein, very low-density lipoprotein, and triglyceride levels, and can moderately increase high-density lipoprotein cholesterol.

HMG-CoA reductase inhibitor that reduces serum total cholesterol concentrations and inhibits cholesterol synthesis. Used in the treatment of primary hypercholesterolaemia where other treatments are ineffective or intolerable and the cholesterol level exceeds 7.8 mmol/L...

Has the effect of lowering cholesterol, LDL cholesterol and VLDL cholesterol.

Why "99% USP/EP Pharmaceutical Grade" is the 2026 Standard

1. High Crystalline Purity (≥ 99.0%): In 2026, precision is non-negotiable. Pharmaceutical-grade Simvastatin Powder must be HPLC-verified to ensure minimal related substances (like lovastatin residues), reducing the risk of myopathy or liver enzyme elevation.

2. Lactone/Acid Balance: As a prodrug, Simvastatin is administered in its inactive lactone form, which is then hydrolyzed in the liver. 2026 standards require strict control over this conversion ratio to ensure predictable pharmacokinetics.

3. Stability & Antioxidant Integration: Simvastatin is sensitive to oxidation. Premium 2026 powders are often co-packaged under Nitrogen-purged environments with trace amounts of antioxidants (like BHA) to maintain potency for 36+ months.

Drug interactions of Simvastatin.

1，When simvastatin is used with anticoagulants, the dose of anticoagulants should be reduced. In addition, this product should not be used in combination with erythromycin, immunosuppressive drugs, phenoxyaromatic acid, and niacin, etc., or else myopathy or even rhabdomyolysis may easily occur.

2, Combined with resin lipid-lowering drugs, it can increase the effect of lipid-lowering and can reduce the amount of drugs and side effects. In the prevention of atherosclerosis and coronary heart disease, it can be combined with Probucol.

This product can increase the efficacy of coumarin anticoagulants such as warfarin, and the dosage of the latter should be reduced when used in combination.

3, this product can moderately increase the anticoagulant effect of bicoumarin anticoagulants; simvastatin and other drugs in therapeutic doses on the cytochrome P450A4 have significant inhibition of the drug (such as cyclosporine, ketoconazole, erythromycin, clarithromycin, nicotinic acid) in combination with an occasional increase in the risk of rhabdomyolysis, should be vigilant.

4, Increased risk of rhabdomyolysis has been observed in combination with other drugs with significant inhibitory effects on cytochrome P4503A4 at therapeutic doses (e.g., cyclosporine, mibefradil, itraconazole, ketoconazole, erythromycin, clarithromycin, and nefazodone), or with fibric acid derivatives, or with niacin.

5, Combination with fibrates increases the incidence and severity of myopathy.

6, Simvastatin moderately increases the anticoagulant effect of coumarin anticoagulants; prothrombin time should be checked when combined.

Pharmacological Effect of  Bulk Simvastatin Powder.

1, It is an inhibitor of 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase, inhibits endogenous cholesterol synthesis, and is a hypolipidemic drug.

2, Simvastatin can reduce normal and elevated low-density lipoprotein cholesterol (LDL-C) levels. Low-density lipoprotein (LDL) is produced from very low-density lipoprotein (VLDL) and is metabolised mainly by binding to LDL receptors.

The mechanism of action of simvastatin in lowering LDL lies in the reduction of VLDL cholesterol concentration and the induction of LDL receptors, which leads to a reduction in the production and/or an increase in the catabolism of LDL-C.

3, Apolipoprotein B (ApoB) also decreases during simvastatin treatment. Because each LDL particle contains one molecule of ApoB, and because only a small amount of ApoB is found in patients with predominantly elevated LDL-C (without concomitant elevation of VLDL), both suggest that simvastatin not only lowers cholesterol by lowering LDL, but also reduces the concentration of LDL particles in the periphery.

In addition, simvastatin reduces VLDL and triglycerides (TG) and increases HDL-C. The effect of simvastatin on lipoprotein (alpha), fibrinogen, and other biochemical markers of coronary artery disease is not known.

Frequently Asked Questions.

In 2026, we categorize them by "Intensity." While Atorvastatin is "High-Intensity," Simvastatin is considered "Moderate-Intensity" and is often preferred for patients who require a stable, well-tolerated long-term profile with a lower risk-to-benefit ratio in specific populations.

A breakthrough 2026 application for Simvastatin powder is in Bone Tissue Engineering. At low concentrations, it promotes the expression of BMP-2, helping to grow new bone in dental implants or fracture sites.

While not an approved use, 2026 "Geroscience" researchers study Simvastatin for its Anti-Inflammatory effects on the vascular system, which may slow down the "age-related stiffening" of the arteries.

The most common therapeutic range for final formulations is 10mg to 40mg daily, usually taken in the evening to align with the peak of nocturnal cholesterol synthesis.

Поставщик порошка Симвастатина 40 мг по оптовой цене
Fournisseur de poudre de Simvastatine 40 mg à prix de gros
Großhandelslieferant für Simvastatin 40 mg Pulver
Proveedor de polvo de Simvastatina 40 mg al por mayor
Fornecedor de pó de Sinvastatina 40 mg no preço de atacado